Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nonmelanoma skin cancers (NMSC) are the most frequently observed cancers in solid organ transplant recipients (SOTR) and may have a significant disease burden. OBJECTIVE: To provide an update regarding the epidemiology and management of NMSC in SOTR. RESULTS: Ten-year incidence rates range from 10% in Italy to 20% in Northern Europe to 70% in Australia. More than 50% of NMSC are located on sun-exposed areas (head, dorsum of hands). Many risk factors have been identified, including age at transplantation, fair skin, type of immunosuppressive drugs, cumulative sun exposure, viral infections, and various genetic markers. Patients with a first NMSC have a 49 times higher risk of developing a subsequent NMSC. Skin self-examination and photoprotection should be encouraged in all transplanted patients. Long-term skin surveillance, early diagnosis and aggressive treatment of any suspicious lesion, reduction of immunosuppressive therapy, and conversion to m-TOR inhibitors can be also effective measures for reduction of NMSC incidence. CONCLUSIONS: NMSC is the most frequent cancer observed in SOTR. Early diagnosis, patient education, and modification of immunosuppression are effective measures for reduction of NMSC incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Valverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999
Cited by
Skin Cancer: An Overview of Epidemiology and Risk Factors
Gordon, R. (2013) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2013.06.002 · Cited by 426
Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States
Garrett, G. L., Blanc, P. D., Boscardin, J., Lloyd, A. A., Ahmed, R. L., Anthony, T., Bibee, K., Breithaupt, A., Cannon, J., Chen, A., et al. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.4920 · Cited by 306
Werner, R. N., Stockfleth, E., Connolly, S. M., Correia, O., Erdmann, R., Foley, P., Gupta, A. K., Jacobs, A., Kerl, H., Lim, H. W., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13180 · Cited by 297
Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety
Snaidr, V. A., Damian, D. L., & Halliday, G. M. (2019) · Experimental Dermatology · doi:10.1111/exd.13819 · Cited by 121
Metabolic consequences of modern immunosuppressive agents in solid organ transplantation
Bamgbola, O. (2016) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816641580 · Cited by 85
“It is also known for reduction of the more frequent occurrence of nonmelanoma carcinoma in SOT recipients [Tessari and Girolomoni, 2012].”
Background
Metadata
- Authors
- Tessari, G., & Girolomoni, G.
- Venue
- Dermatologic Surgery
- Published
- 2012-10
- Volume
- 38
- Issue
- 10
- Pages
- 1622-1630
- ISSN
- 1076-0512 (ISSN-L)
- OpenAlex
- W2060328350
- Cited by
- 110
- References
- 2
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management. https://app.cochat.ai/papers/10.1111/j.1524-4725.2012.02520.x
- The paper
- Tessari, G., & Girolomoni, G. (2012). Nonmelanoma Skin Cancer in Solid Organ Transplant Recipients: Update on Epidemiology, Risk Factors, and Management. Dermatologic Surgery. https://doi.org/10.1111/j.1524-4725.2012.02520.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.